Long COVIDlike so many invisible illnessesis far more impactful than many healthy individuals realize. A new study out of the U.K. reveals the extreme extent...
Syphilis has nearly doubled in numbers for young people in B.C. over the last five years, and health experts say it's important for youthto get tested as the...
Millions have an abnormal heart rhythm or arrythmia and many don't even realise it. The most common type is atrial fibrillation (AF), which causes an...
By Cara Murez HealthDay Reporter FRIDAY, June 9, 2023 (HealthDay News) -- The percentage of cancer survivors who struggle with a disability has doubled in...
A deadly bacteria that kills up to 50 percent of people it infects was recently detected at the Mayo Clinic in Arizona. Three laboratory workers were exposed...
By Cara Murez HealthDay Reporter THURSDAY, June 8, 2023 (HealthDay News) -- Patients who develop a devastating heart condition have new reason to hope after...
When he proposed that the human papillomavirus caused cervical cancer, he was ridiculed. He persevered, and today a vaccine exists. Dr. Harald zur Hausen, a...
A toddler's cancer was misdiagnosed as constipation by blundering NHS medics. Ella Formby-Smith, three, had been 'back and forth' to hospital since she was...
A well-known, inexpensive diabetes drug appears to cut the risk of developing long COVID, hopeful-but-early new research suggests. The study, published...
The Supreme Court of Canada will not hear the appeal of an Alberta woman who was unwilling to be vaccinated against COVID-19 in order to get a life-saving...
Vertex Pharmaceuticals Incorporated VRTX and CRISPR Therapeutics AG CRSP announced that pivotal trials for exagamglogene autotemcel (exa-cel) for...
A healthy man says he was given 12 hours to live after contracting hepatitis B through an infected nail. David Surtees was working a typical day delivering...
Roche Group Holdings AG's RHHBY data from the global phase 3 COMMODORE 1 and 2 studies evaluating crovalimab compared to eculizumab, a current standard of...
IPH6501 is a first-in-class tetra-specific antibody-based natural killer cell engager therapeutic, based on ANKET platform, targeting CD20 developed for the...
-- Data from the RLYB212 Phase 1b Proof-of-Concept Study to be Featured as an Oral Presentation at ISTH -- -- Company to Host Webcast Following ISTH Oral...
AstraZeneca Plc AZN released data from the Phase 3 ALPHA trial of danicopan as an add-on to the standard of care for paroxysmal nocturnal hemoglobinuria...
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announced the first...
A fourth Texan has died from fungal meningitis, the Centers for Disease Control and Prevention has reported. The CDC has warned anyone who was given an...
By Hamish Mureddu-Reid & Mark Norman BBC News The wife of Kent man who was put on a "momentous" drug developed to fight Alzheimer's says it has given the...
Three-quarters of GP surgeries are breaching safety limits, MailOnline can reveal today. Health chiefs say patient-doctor ratios should never exceed 1,800....